CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation
Sehhoon Park, Bo Mi Ku, Hyun Ae Jung, Jong-Mu Sun, Jin Seok Ahn, Se-Hoon Lee, Keunchil Park, Myung-Ju Ahn
Cancer Research and Treatment. 2020;52(4):1288-1290.   Published online 2020 June 22    DOI:

Excel Download

ID3021 Acquired resistance to with EGFR tyrosine kinase inhibitors by the EGFR T790M mutation in non-small cell lung cancer
Biomedical Research and Therapy. 2017;4(S):33   Crossref logo
Link1 Link2

Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3 -mutation, localized transformation to EGFR -mutated SCLC, and acquired T790M EGFR -mutation
Lung Cancer. 2017;113:14-17   Crossref logo
Link1 Link2

C797S and T790M EGFR Mutations in Non–Small Cell Lung Cancer: In Trans or in Separate Clones?
Journal of Thoracic Oncology. 2018;13(2):e21-e22   Crossref logo
Link1 Link2

Osimertinib-induced Stevens-Johnson syndrome in a patient with EGFR T790M mutation-positive non-small cell lung cancer
Lung Cancer. 2019;129:110-111   Crossref logo
Link1 Link2

Respirology. 2017;22:18-19   Crossref logo
Link1 Link2

Australian recommendations for EGFR T790M testing in advanced non-small cell lung cancer
Asia-Pacific Journal of Clinical Oncology. 2017;13(4):296-303   Crossref logo
Link1 Link2

EGFR Mutation and Resistance of Non-Small-Cell Lung Cancer to Gefitinib
Yearbook of Oncology. 2006;2006:228-229   Crossref logo
Link1 Link2

EGFR T790M resistance mutation in non small-cell lung carcinoma
Clinica Chimica Acta. 2015;444:81-85   Crossref logo
Link1 Link2

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
Nature Medicine. 2015;21(6):560-562   Crossref logo
Link1 Link2 Link3

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer
Lung Cancer. 2018;126:133-138   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.